Around 88% of the bodies set up to deliver health care across England are not implementing national guidelines aimed at minimizing the risk of antibiotic resistance.
Those are the findings of a Freedom of Information Act request submitted by a charity representing patients to find out to what extent Clinical Commissioning Groups (CCGs) are following the 2015 Antimicrobial Stewardship (AMS) guidelines.
These instructions were introduced by the government’s National Institute for Health and Care Excellence (NICE), and warned that they pose a huge global health risk, and one of the most significant threats to patients' safety in the UK.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze